(Q43492808)

24 November 2017

title

Cost-efficacy analysis of the MONET trial using UK antiretroviral drug prices (English)

1 reference

24 November 2017

Brian Gazzard

1

1 reference

24 November 2017

Andrew Hill

series ordinal

2

1 reference

24 November 2017

Anne Anceau

series ordinal

3

1 reference

24 November 2017

publication date

1 July 2011

1 reference

Applied Health Economics and Health Policy

24 November 2017

published in

1 reference

24 November 2017

volume

9

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

217-223

1 reference

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11592220-000000000-00000

British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592220-000000000-00000

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592220-000000000-00000

Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592220-000000000-00000

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592220-000000000-00000

10.2165/11592220-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1042630136

0 references

1 reference